Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support

J Clin Oncol. 2006 May 20;24(15):2392-4; author reply 2394-5. doi: 10.1200/JCO.2006.05.7174.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / therapy
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Humans
  • Leukocytosis / chemically induced*
  • Mastectomy
  • Myeloproliferative Disorders / chemically induced
  • Neutropenia / chemically induced
  • Polyethylene Glycols
  • Radiotherapy
  • Recombinant Proteins
  • Taxoids / administration & dosage

Substances

  • Recombinant Proteins
  • Taxoids
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Filgrastim